Opinion: Understanding the FDA’s Take on Cannabidiol
In a statement announcing a newly created partnership, the Botanical Safety Consortium, FDA Commissioner Scott Gottlieb made no mention of cannabidiol.
Pancreatic Cancer
PANCREATIC CANCER ADVISOR
FEATURED CONTENT
-
-
Reducing the Reliance on Opioids for Cancer Pain: Is the Switch to Cannabis a Viable Option?
Articles discussing the use of cannabis as a substitute for opioids highlight the limitations of the existing scientific evidence in the field. -
Should Widespread Early Detection Cancer Screening End?
Experts examined the role of population-based early detection cancer screening. -
Checkpoint Inhibitors Boost Cancer Vaccine Research
Researchers are excited about the prospect to use vaccines in combination with checkpoint inhibitors to improve the body’s cancer-fighting ability. -
Is Real-World Evidence a Complement to Randomized Clinical Trials?
Use of real-world data has the potential to accelerate drug and device approvals in rare diseases and advance precision medicine initiatives.
PANCREATIC CANCER NEWS
Predicting Benefit From Olaparib Maintenance in Metastatic Pancreatic Cancer: The POLO Trial
The Incidence of Some Obesity-Related Cancers Is Increasing Among Young Adults
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Phase 1, 2 Trials to Assess Imaging System for Gastrointestinal Cancer Detection
Effect of Neuroendocrine Tumor Classification Updates on Survival Rates in Pancreatic Cancer
Want to read more?
Please login or register first to view this content.
Next post in Pancreatic Cancer
